Supreme Court Talks Cannabis Rescheduling in Gun Rights Hearing
The cannabis rescheduling regulatory impact is critical for clinicians monitoring federal and state legal changes. These changes affect prescribing options, research access, and liability protections. Understanding this impact helps providers navigate…
Impact of Maternal Cannabis Use During Peripregnancy on Child Development
Maternal cannabis use peripregnancy is linked to behavioral and developmental differences in children. These effects vary depending on autism spectrum disorder symptoms. This research highlights the importance of understanding cannabis exposure during…
Endocannabinoid System Research: GLP-1 and Mental Health Insights
GLP-1 receptor agonists mental health effects were examined using Mendelian randomization to assess their impact on common mental illnesses. This genetic study suggests a potential causal link between GLP-1 receptor agonists and reduced schizophrenia…
Cannabinoid Clinical Trials: Cannabis Intervention for Teens
Sequential cannabis prevention messaging adolescents shows promise in overcoming resistance to cannabis prevention efforts. Tailored, multi-message approaches address diverse attitudes among teens. This strategy may enhance effectiveness in reducing…
Endocannabinoid System: Cannabis, Pregnancy & Cytokines
Cannabis use during pregnancy is linked to suppression of maternal immune signaling proteins called cytokines. This immune modulation may impact pregnancy health and fetal development. Understanding cannabis use during pregnancy is critical for informed…
Endocannabinoid System & Cannabis-Induced Psychosis Research
Cannabis-induced psychosis schizophrenia risk is a critical concern for clinicians. A significant portion of patients with cannabis-induced psychosis later develop schizophrenia spectrum or bipolar disorder. Early identification and structured follow-up…
Cannabinoid Clinical Trials: Digital Smoking Cessation for HIV
This pilot trial evaluates digital therapeutics smoking cessation HIV interventions tailored for people living with HIV. The study shows strong feasibility and acceptability of app-based cessation tools in this population. Digital therapeutics offer a…
Cannabidiol for Lennox-Gastaut: Clinical Trial Evidence and Insights
Clinically meaningful cannabidiol reduction offers new hope for Lennox-Gastaut syndrome patients by improving drop seizure outcomes. Recent clinical trials demonstrate that even reductions below 50% can be impactful. Caregiver reports support…
Endocannabinoid System Research: Cannabis for Endometriosis
Many people with endometriosis use cannabis for symptom relief, but clinical evidence is limited. This medicinal cannabis endometriosis trial evaluated safety and feasibility of inhaled THC and oral CBD oil. The study highlights challenges in conducting…
Cannabinoid Clinical Trials: CBD and WADA Drug Testing
2026 cannabis clinical trials reveal that broad-spectrum CBD supplements can lead to detectable WADA-prohibited cannabinoids in urine. Exercise amplifies these concentrations, increasing doping risk. Athletes should be cautious with CBD products to avoid…